hematology analysis Articles
-
Sight Diagnostics raises $71M Series D for its blood analyzer
Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D round with participation from Koch Disruptive Technologies, Longliv Ventures (which led its Series C round) and crowd-funding platform OurCrowd. With this, the company has now raised a total of $124 million, though the company declined to ...
-
Mid-Size Laboratories Can Now Enjoy the Same Efficiency Benefits as Large Facilities with Beckman Coulter’s New Hematology Analyzer
Beckman Coulter , a global leader in clinical diagnostics, today announced the commercial launch of its new DxH 690T hematology analyzer. Designed to help laboratories streamline workflow and maximize uptime, the DxH 690T offers all the benefits of the company’s flagship DxH 900 hematology analyzer to mid-size labs, including an industry-leading 93% first-pass yield and the recently ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you